Market Capitalization: Omeros Corp (OMER)

Public company logo of Omeros Corp. (OMER)

The market value dynamics of Omeros Corporation (OMER), which currently stands at 1.26, illustrate the position of a biopharmaceutical player with a diverse portfolio of projects in immunology, ophthalmology, and neurology. The company is currently focused on the independent development of its proprietary research and the search for strategic partners for commercialization. Holding exclusive rights to MASP-2 molecules allows the business to exercise pricing power in the therapy of inflammatory processes.

OMER Omeros Corp: Market Value in the range 07/04/2022 - 11/16/2026

OMER (Omeros Corp.): analytical breakdowns and indicator data

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:OMER (Omeros)
Product sample of Omeros Corp

The development progress of innovative drugs by Omeros Corporation (OMER) to combat rare inflammatory diseases is directly reflected in the public company's market capitalization. This indicator captures the total value of equity, filtering out market noise from the long-term trend. The calculation is based on the product of the current share price and the total number of outstanding securities. Growth in this metric confirms market confidence in the business's molecular research. A steady upward vector indicates the fundamental stability of the asset.

Key competitors

Market Capitalization BIIB (Biogen Idec)|Neurocrine Biosciences Inc - Market Value|regencellbioscience.com - Market Capitalization|Market Capitalization axsome.com AXSM|ACAD: Market Capitalization|Market Value Xenon Pharmaceuticals Inc. (XENE)|Market Value Viking Therapeutics|Market Capitalization SUPN (Supernus Pharma)|Market Capitalization CPRX|DNLI - Market Value|harmonybiosciences.com - Market Valuation|Market Capitalization Biohaven Ltd BHVN|AMLX - Market Value|Market Value TRVI (Trevi Corp)|Praxis Precision Medicines Inc (PRAX) - Market Value|Market Value Anavex Life Sciences (AVXL)|CBLL (CeriBell Inc) - Market Capitalization|Prothena Corporation - Market Valuation|Market Value Alector (ALEC)|Annexon Biosciences Inc. - Market Capitalization|Neurogene Therapeutics - Market Valuation|Market Value ACIU|voyagertherapeutics.com - Market Capitalization|Neumora (NMRA) - Market Valuation|SCLX: Market Capitalization|Market Capitalization Tevogen Bio Holdings, Inc. TVGN|Market Valuation ACOG|CGTX (Cognition Therapeutics, Inc.) - Market Value|Market Capitalization IKT|Market Capitalization Cassava (SAVA)|Market Value Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Market Value|VTGN: Market Valuation|Market Value OVID (ovidrx.com)|ABOS: Market Capitalization|CRVO - Market Capitalization|ATHE (alteritytherapeutics.com) - Market Capitalization|Market Valuation clene.com (CLNN)|Market Value pepgen.com (PEPG)|JUNS (Jupiter Neurosciences, Inc.) - Market Value|Market Capitalization RLMD (relmada.com)|Market Capitalization Annovis Bio Inc (ANVS)|GRCE: Market Valuation|Market Capitalization Firefly Neuroscience Inc AIFF|KLTO: Market Capitalization|NeuroSense Therapeutics Ltd - Market Value|Market Valuation RVPH|Market Capitalization MTVA (MetaVia Inc)|Market Value NeurAxis Inc (NRXS)|Helius Medical Technologies Inc. - Market Capitalization|Market Capitalization PASG (Passage Bio Inc.)|Market Capitalization bionomics.com.au NEUP|Minerva Neurosciences Inc - Market Capitalization|ATHA - Market Capitalization|ADXN: Market Capitalization|Alzamend (ALZN) - Market Capitalization|CYCN (cyclerion.com) - Market Capitalization|Protagenic Therapeutics (PTIX) - Market Capitalization|Market Value pasitheaclinics.com (KTTA)|CRGT (Cortigent Inc) - Market Value|Market Capitalization ATXI (Avenue Therapeutics Inc)|Market Value BCLI|Cara Therapeutics Inc - Market Capitalization|Chromocell Therapeutics (CHRO) - Market Valuation|ELYM (Eliem Therapeutics Inc.) - Market Valuation|ITCI - Market Capitalization|Market Value Longboard Pharma|Market Capitalization MRNS (Marinus Pharma)|Market Value NKGen Biotech Inc (NKGN)|NRBO - Market Value|Market Capitalization SAGE (Sage Therapeutics Inc)|Synaptogenix Inc. (SNPX) - Market Value|TRVN: Market Valuation|Market Capitalization vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Market Valuation|Market Valuation Cerevel Therapeutics